Sort
261,768 grants matching “gene therapy”
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
$2,028,370John M. Sedivy · Brown University · P01 · FY2016 · AG
ACTIVATION OF HEMOSTASIS
$2,028,082University Of Pennsylvania · P50 · FY2000 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,028,003Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2019 · HL
Environmental regulation of estrogen responsive genes in single living cells
$2,027,983Joseph Rodriguez · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Pathogensis of Chlamydial Infection
$2,027,709Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Interleukin-13 in Experimental Asthma
$2,027,678Marsha W Wills-Karp · Cincinnati Childrens Hosp Med Ctr · P01 · FY2008 · HL
Plasma Cells in Health and Disease
$2,027,642Ignacio E. Sanz · Emory University · P01 · FY2017 · AI
Human T-Cell Responses to Tumor Antigens
$2,027,509Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,506Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2020 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,452Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2021 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,405Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2022 · HL
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,027,385Redford B Williams · Duke University · P01 · FY2020 · HL
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
$2,027,150Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Plasma Cells in Health and Disease
$2,026,518Ignacio E. Sanz · Emory University · P01 · FY2019 · AI
Gene Therapy for Hemophilia
$2,026,513Mortimer Poncz · Children'S Hosp Of Philadelphia · P01 · FY2014 · HL
Alzheimer's DIsease Research Center
$2,025,974Steven T Dekosky · University Of Pittsburgh At Pittsburgh · P50 · FY2006 · AG
Plasma Cells in Health and Disease
$2,025,932Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Novel Therapeutic Approaches for Parkinson's Disease
$2,025,533Mc Lean Hospital (Belmont, Ma) · P50 · FY2005 · NS
The role of methylation-sensitive PP2A isoforms in regulating the pathological response to tau
$2,025,000Ottavio Arancio · Columbia University Health Sciences · RF1 · FY2018 · AG
Airway inflammation and HLA-G in asthma
$2,024,941Steven R White · University Of Chicago · U19 · FY2011 · AI
NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)
$2,024,745Lovelace Biomedical Research Institute · N01 · FY2025 · OD
Interleukin-13 in Experimental Asthma
$2,024,400Marsha W Wills-Karp · Cincinnati Childrens Hosp Med Ctr · P01 · FY2006 · HL
Prevention of AIDS
$2,024,238Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$2,023,730Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2017 · CA